On Sunday’s episode of The Excerpt podcast: Brain-computer interfaces promise breakthroughs in restoring lost function and beyond. But they also raise ethical and societal questions about the linking ...
Elon Musk co-founded Neuralink in 2016 to develop brain-machine interfaces. The first product — the N1 implant — focuses on allowing patients with paralysis to control computer cursors with their mind ...
For someone who has lost the ability to speak, a thought can feel trapped with no way out. Research on brain-computer ...
What the world’s fastest brain-typist is telling us about the future of computer interfaces. In a 12-by-20-foot room at a skilled-nursing facility in Menlo Park, California, researchers are testing ...
Brain-computer interfaces are a groundbreaking technology that can help paralyzed people regain functions they’ve lost, like moving a hand. These devices record signals from the brain and decipher the ...
A new kind of neural interface system that coordinates the activity of hundreds of tiny brain sensors could one day deepen understanding of the brain and lead to new medical therapies. Brain-computer ...
One day in the future, we may interact with our electronic devices not with physical input or even voice commands, but simply by thinking about what we want to do. Such brain–computer interfaces (BCIs ...
One of the boldest emerging sciences is the field of brain-computer interfaces (BCIs). Broadly speaking, BCIs are essentially tools by which brain signals and thoughts can be relayed into tangible ...
Forget those futuristic interfaces controlled with waving hands. That'll get old. Brainwaves are the ultimate control, and are, in fact, about the only channel open to severely disabled people.
Brain computer interfaces may sound futuristic, but adoption of such systems -- which allow signals from the brain to be recorded or used to control technology -- is on the rise. Much of the ...
When Ian Burkhart was just 19 years old, he lost the ability to move below his elbows after a diving accident. Three years later, he came across a clinical trial that would begin in 2013 and could ...